2023 Archives - Page 7 of 8

Scancell to present ModiFY Phase 1/2 cancer vaccine clinical trial protocol and early efficacy data at the American Association for Cancer Research Annual Meeting

by admin | Apr 18, 2023 | Latest News, Modi-1, Moditope, Regulatory News

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory pool

by admin | Apr 17, 2023 | Moditope, Vaccines

Ruhul H. Choudhury, Ian Daniels, Poonam Vaghela, Suha Atabani, Thomas Kirk, Peter Symonds, Katherine W. Cook, Abdullah Al-Omari, Daisy Weston, Sabaria Shah, David Hutchinson, Samantha J. Paston, Rachael L. Metheringham, Victoria A. Brentville, Lindy G. Durrant...

Block Listing Application to AIM

by admin | Apr 17, 2023 | Latest News, Regulatory News

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Scancell Statement re: Silicon Valley Bank (SVB)

by admin | Mar 13, 2023 | Latest News, Regulatory News

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Encouraging early efficacy data from monotherapy part of ModiFY Phase 1/2 clinical trial

by admin | Feb 21, 2023 | Latest News, Moditope

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

« Older Entries

Next Entries »

Scancell to present ModiFY Phase 1/2 cancer vaccine clinical trial protocol and early efficacy data at the American Association for Cancer Research Annual Meeting

Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory pool

Block Listing Application to AIM

Scancell Statement re: Silicon Valley Bank (SVB)

Encouraging early efficacy data from monotherapy part of ModiFY Phase 1/2 clinical trial

Recent Posts

Recent Comments

ACTIVE IMMUNOTHERAPY

ANTIBODIES